Skip to content
Review Open access

TMAO at the Crossroads of the Gut–Brain Axis: Emerging Mechanisms Linking Microbiota-Derived Metabolites to Neuroinflammation and Cognitive Dysfunction

Oct 2026 · Cells · Vol 15 · 0 citations · 105 references
Medicine

TL;DR

The potential use of TMAO and its precursors as therapeutic targets for multiple neurodegenerative disorders is suggested, however, the need for conducting large, adequately powered randomized clinical studies to determine its therapeutic relevance is emphasized.

Abstract

Highlights What are the main findings? TMAO is increasingly recognized as a potential target linking gut microbial metabolism with neurovascular dysfunction and neurodegenerative diseases. Experimental and clinical evidence suggests that TMAO may affect neurological health through combined mechanisms involving oxidative stress, neuroinflammation, endothelial dysfunction, blood–brain barrier integrity, and altered gut–brain axis signaling. What are the implications of the main findings? Understanding how TMAO and other microbial metabolites affect neurovascular, inflammatory, and cellular signaling pathways could identify underrecognized mechanisms linking gut microbial mechanisms with neurological dysfunction. Modulation of TMAO synthesis and metabolism may provide a new therapeutic strategy to mitigate or slow the progression of neurological and cerebrovascular diseases. Abstract Trimethylamine-N-oxide (TMAO) is a gut microbiota-derived metabolite produced through the hepatic oxidation of trimethylamine. Although TMAO has been widely investigated as a therapeutic target in multiple cardiovascular and metabolic diseases, growing evidence suggests it may play a critical role in the neuroinflammation and cognitive dysfunction associated with the gut–brain axis. This narrative review summarizes the current literature to synthesize evidence on the mechanisms linking TMAO with neurological disorders; it discusses potential mechanisms contributing to this association, with particular focus on neuroinflammation, oxidative stress, and activation of inflammatory pathways. Overall, this review also suggests the potential use of TMAO and its precursors as therapeutic targets for multiple neurodegenerative disorders. However, it emphasizes the need for conducting large, adequately powered randomized clinical studies to determine its therapeutic relevance.

Read PDF

Similar papers

Review Sep 2026

Exploring the neuroprotective potential of saponins through the gut microbiota-brain axis: a narrative review of emerging mechanisms and research directions.

Neurodegenerative diseases are defined as progressive and irreversible disorders involving the degeneration of neurons in the brain, giving rise to both cognitive deterioration and motor dysfunction. Diseases such as Alzheimer's, Parkinson's, and Huntington's pose major public health challenges, particularly in aging p...

Kainat Fatima, Ha-Seong Cho, Ibukunoluwa Fola Olawuyi et al. · 0 citations
Review Sep 2026

Deconstructing the microbiota-gut-brain axis in multiple sclerosis: from a barrier-immune-metabolic framework to emerging therapeutics.

The gut microbiota may influence MS pathophysiology through a coordinated barrier-immune-metabolic axis, and microbiome-targeted interventions show promising therapeutic potential, but translation into clinical practice requires further mechanistic validation and well-controlled human studies.

Jin-Xin Wang, Fang Zheng, Yu-Chen Zhang et al. · 0 citations
Review Aug 2026

The Emerging Role of Peripheral Anti-Inflammatory Agents in Modulating Neurodegenerative Pathology: A Cross-Domain Review

This review synthesizes recent advances in understanding how peripheral immunity and gut microbiota influence neurodegenerative processes, highlighting key signaling pathways and mechanisms and examines current therapeutic strategies.

Vishwadeep Singh, V. Saxena, Sanskriti Upadhyay · 0 citations
Review Open access Oct 2026

Targeting the gut–brain axis: novel strategies for disease intervention from mechanisms to clinical practice

The gut–brain axis is a bidirectional communication network linking the gastrointestinal tract and the central nervous system (CNS), in which the gut microbiota and its metabolites have emerged as important modulators. Alterations in the gut microbiota have been reported in a range of neurological, psychiatric, and met...

Le-Le Fan, Yu Guo, Jin Liu et al. · 0 citations
Review Sep 2026

The Gut-Brain Axis: Exploring the Role of Gut Microbiota in Alzheimer's Disease Pathogenesis and Therapeutics.

The gut microbiota acts as an upstream regulator of AD pathology through interconnected molecular mechanisms, and microbiota-targeted interventions have the potential to modulate these pathways and improve cognitive outcomes, although results vary across studies.

Javeria Fatima, Y. Siddique · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.